# A Pilot Study of Ketogenic Diet and Metformin in Glioblastoma: Feasibility and Metabolic Imaging

> **NCT04691960** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Weill Medical College of Cornell University** · enrollment: 18 (actual)

## Conditions studied

- Glioblastoma

## Interventions

- **OTHER:** Ketogenic Diet
- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT04691960
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2016-08
- **Primary completion:** 2026-06
- **Final completion:** 2026-06
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2025-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04691960

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04691960, "A Pilot Study of Ketogenic Diet and Metformin in Glioblastoma: Feasibility and Metabolic Imaging". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04691960. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*